Does USTEKINUMAB Cause Product dose omission? 1,653 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,653 reports of Product dose omission have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.9% of all adverse event reports for USTEKINUMAB.
1,653
Reports of Product dose omission with USTEKINUMAB
1.9%
of all USTEKINUMAB reports
3
Deaths
122
Hospitalizations
How Dangerous Is Product dose omission From USTEKINUMAB?
Of the 1,653 reports, 3 (0.2%) resulted in death, 122 (7.4%) required hospitalization.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,653 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
TOFACITINIB (1,104)
Which USTEKINUMAB Alternatives Have Lower Product dose omission Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE